 | • レポートコード：MRC2-11QY09861 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はソマトスタチン類似体のグローバル市場について調査・分析したレポートです。種類別（オクトレオチド、ランレオチド、パシレオチド）市場規模、用途別（先端巨大症、カルチノイド症候群、神経内分泌腫瘍、クッシング症候群、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ソマトスタチン類似体の競争状況、市場シェア ・世界のソマトスタチン類似体市場：種類別市場規模 2015年-2020年（オクトレオチド、ランレオチド、パシレオチド） ・世界のソマトスタチン類似体市場：種類別市場規模予測 2021年-2026年（オクトレオチド、ランレオチド、パシレオチド） ・世界のソマトスタチン類似体市場：用途別市場規模 2015年-2020年（先端巨大症、カルチノイド症候群、神経内分泌腫瘍、クッシング症候群、その他） ・世界のソマトスタチン類似体市場：用途別市場規模予測 2021年-2026年（先端巨大症、カルチノイド症候群、神経内分泌腫瘍、クッシング症候群、その他） ・北米のソマトスタチン類似体市場分析：米国、カナダ ・ヨーロッパのソマトスタチン類似体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのソマトスタチン類似体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のソマトスタチン類似体市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのソマトスタチン類似体市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Peptron、Chiasma、Ipsen Biopharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Somatostatin analogues stop your body from making too many hormones. They can reduce the symptoms of carcinoid syndrome and may slow down tumour growth.
Somatostatin is a protein made naturally in the body. It is made by: a gland in the brain (hypothalamus), the stomach, the pancreas and the bowel. Somatostatin can slow down hormone production, including many of the gut hormones, slows down the emptying of the stomach and bowel, controls the release of hormones made by the pancreas, including insulin and, slows down or stops the release of growth hormones. Rise in the research and development and launch of novel drug therapies are the factors driving the growth of somatostatin analogs over the forecast period.
Market Analysis and Insights: Global Somatostatin Analogs Market
The global Somatostatin Analogs market size is projected to reach US$ 4639.5 million by 2026, from US$ 4400 million in 2020, at a CAGR of 5.0%% during 2021-2026.
Global Somatostatin Analogs Scope and Market Size
Somatostatin Analogs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Somatostatin Analogs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Somatostatin Analogs market is segmented into
Octreotide
Lanreotide
Pasireotide
Segment by Application, the Somatostatin Analogs market is segmented into
Acromegaly
Carcinoid Syndrome
Neuroendocrine Tumor
Cushing Syndrome
Others
Regional and Country-level Analysis
The Somatostatin Analogs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Somatostatin Analogs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Somatostatin Analogs Market Share Analysis
Somatostatin Analogs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Somatostatin Analogs business, the date to enter into the Somatostatin Analogs market, Somatostatin Analogs product introduction, recent developments, etc.
The major vendors covered:
Novartis
Peptron
Chiasma
Ipsen Biopharmaceutical
…
1 Study Coverage
1.1 Somatostatin Analogs Product Introduction
1.2 Market Segments
1.3 Key Somatostatin Analogs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Somatostatin Analogs Market Size Growth Rate by Type
1.4.2 Octreotide
1.4.3 Lanreotide
1.4.4 Pasireotide
1.5 Market by Application
1.5.1 Global Somatostatin Analogs Market Size Growth Rate by Application
1.5.2 Acromegaly
1.5.3 Carcinoid Syndrome
1.5.4 Neuroendocrine Tumor
1.5.5 Cushing Syndrome
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Somatostatin Analogs Market Size, Estimates and Forecasts
2.1.1 Global Somatostatin Analogs Revenue 2015-2026
2.1.2 Global Somatostatin Analogs Sales 2015-2026
2.2 Global Somatostatin Analogs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Somatostatin Analogs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Somatostatin Analogs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Somatostatin Analogs Competitor Landscape by Players
3.1 Somatostatin Analogs Sales by Manufacturers
3.1.1 Somatostatin Analogs Sales by Manufacturers (2015-2020)
3.1.2 Somatostatin Analogs Sales Market Share by Manufacturers (2015-2020)
3.2 Somatostatin Analogs Revenue by Manufacturers
3.2.1 Somatostatin Analogs Revenue by Manufacturers (2015-2020)
3.2.2 Somatostatin Analogs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Somatostatin Analogs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Somatostatin Analogs Revenue in 2019
3.2.5 Global Somatostatin Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Somatostatin Analogs Price by Manufacturers
3.4 Somatostatin Analogs Manufacturing Base Distribution, Product Types
3.4.1 Somatostatin Analogs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Somatostatin Analogs Product Type
3.4.3 Date of International Manufacturers Enter into Somatostatin Analogs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Somatostatin Analogs Market Size by Type (2015-2020)
4.1.1 Global Somatostatin Analogs Sales by Type (2015-2020)
4.1.2 Global Somatostatin Analogs Revenue by Type (2015-2020)
4.1.3 Somatostatin Analogs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Somatostatin Analogs Market Size Forecast by Type (2021-2026)
4.2.1 Global Somatostatin Analogs Sales Forecast by Type (2021-2026)
4.2.2 Global Somatostatin Analogs Revenue Forecast by Type (2021-2026)
4.2.3 Somatostatin Analogs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Somatostatin Analogs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Somatostatin Analogs Market Size by Application (2015-2020)
5.1.1 Global Somatostatin Analogs Sales by Application (2015-2020)
5.1.2 Global Somatostatin Analogs Revenue by Application (2015-2020)
5.1.3 Somatostatin Analogs Price by Application (2015-2020)
5.2 Somatostatin Analogs Market Size Forecast by Application (2021-2026)
5.2.1 Global Somatostatin Analogs Sales Forecast by Application (2021-2026)
5.2.2 Global Somatostatin Analogs Revenue Forecast by Application (2021-2026)
5.2.3 Global Somatostatin Analogs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Somatostatin Analogs by Country
6.1.1 North America Somatostatin Analogs Sales by Country
6.1.2 North America Somatostatin Analogs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Somatostatin Analogs Market Facts & Figures by Type
6.3 North America Somatostatin Analogs Market Facts & Figures by Application
7 Europe
7.1 Europe Somatostatin Analogs by Country
7.1.1 Europe Somatostatin Analogs Sales by Country
7.1.2 Europe Somatostatin Analogs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Somatostatin Analogs Market Facts & Figures by Type
7.3 Europe Somatostatin Analogs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Somatostatin Analogs by Region
8.1.1 Asia Pacific Somatostatin Analogs Sales by Region
8.1.2 Asia Pacific Somatostatin Analogs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Somatostatin Analogs Market Facts & Figures by Type
8.3 Asia Pacific Somatostatin Analogs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Somatostatin Analogs by Country
9.1.1 Latin America Somatostatin Analogs Sales by Country
9.1.2 Latin America Somatostatin Analogs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Somatostatin Analogs Market Facts & Figures by Type
9.3 Central & South America Somatostatin Analogs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Somatostatin Analogs by Country
10.1.1 Middle East and Africa Somatostatin Analogs Sales by Country
10.1.2 Middle East and Africa Somatostatin Analogs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Somatostatin Analogs Market Facts & Figures by Type
10.3 Middle East and Africa Somatostatin Analogs Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Somatostatin Analogs Products Offered
11.1.5 Novartis Related Developments
11.2 Peptron
11.2.1 Peptron Corporation Information
11.2.2 Peptron Description and Business Overview
11.2.3 Peptron Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Peptron Somatostatin Analogs Products Offered
11.2.5 Peptron Related Developments
11.3 Chiasma
11.3.1 Chiasma Corporation Information
11.3.2 Chiasma Description and Business Overview
11.3.3 Chiasma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Chiasma Somatostatin Analogs Products Offered
11.3.5 Chiasma Related Developments
11.4 Ipsen Biopharmaceutical
11.4.1 Ipsen Biopharmaceutical Corporation Information
11.4.2 Ipsen Biopharmaceutical Description and Business Overview
11.4.3 Ipsen Biopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ipsen Biopharmaceutical Somatostatin Analogs Products Offered
11.4.5 Ipsen Biopharmaceutical Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Somatostatin Analogs Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Somatostatin Analogs Market Estimates and Projections by Region
12.1.1 Global Somatostatin Analogs Sales Forecast by Regions 2021-2026
12.1.2 Global Somatostatin Analogs Revenue Forecast by Regions 2021-2026
12.2 North America Somatostatin Analogs Market Size Forecast (2021-2026)
12.2.1 North America: Somatostatin Analogs Sales Forecast (2021-2026)
12.2.2 North America: Somatostatin Analogs Revenue Forecast (2021-2026)
12.2.3 North America: Somatostatin Analogs Market Size Forecast by Country (2021-2026)
12.3 Europe Somatostatin Analogs Market Size Forecast (2021-2026)
12.3.1 Europe: Somatostatin Analogs Sales Forecast (2021-2026)
12.3.2 Europe: Somatostatin Analogs Revenue Forecast (2021-2026)
12.3.3 Europe: Somatostatin Analogs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Somatostatin Analogs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Somatostatin Analogs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Somatostatin Analogs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Somatostatin Analogs Market Size Forecast by Region (2021-2026)
12.5 Latin America Somatostatin Analogs Market Size Forecast (2021-2026)
12.5.1 Latin America: Somatostatin Analogs Sales Forecast (2021-2026)
12.5.2 Latin America: Somatostatin Analogs Revenue Forecast (2021-2026)
12.5.3 Latin America: Somatostatin Analogs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Somatostatin Analogs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Somatostatin Analogs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Somatostatin Analogs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Somatostatin Analogs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Somatostatin Analogs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Somatostatin Analogs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Somatostatin Analogs Market Segments
Table 2. Ranking of Global Top Somatostatin Analogs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Somatostatin Analogs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Octreotide
Table 5. Major Manufacturers of Lanreotide
Table 6. Major Manufacturers of Pasireotide
Table 7. Global Somatostatin Analogs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Somatostatin Analogs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Somatostatin Analogs Sales by Regions 2015-2020 (K MT)
Table 10. Global Somatostatin Analogs Sales Market Share by Regions (2015-2020)
Table 11. Global Somatostatin Analogs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Somatostatin Analogs Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Somatostatin Analogs Sales Share by Manufacturers (2015-2020)
Table 14. Global Somatostatin Analogs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Somatostatin Analogs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin Analogs as of 2019)
Table 16. Somatostatin Analogs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Somatostatin Analogs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Somatostatin Analogs Price (2015-2020) (USD/MT)
Table 19. Somatostatin Analogs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Somatostatin Analogs Product Type
Table 21. Date of International Manufacturers Enter into Somatostatin Analogs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Somatostatin Analogs Sales by Type (2015-2020) (K MT)
Table 24. Global Somatostatin Analogs Sales Share by Type (2015-2020)
Table 25. Global Somatostatin Analogs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Somatostatin Analogs Revenue Share by Type (2015-2020)
Table 27. Somatostatin Analogs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Somatostatin Analogs Sales by Application (2015-2020) (K MT)
Table 29. Global Somatostatin Analogs Sales Share by Application (2015-2020)
Table 30. North America Somatostatin Analogs Sales by Country (2015-2020) (K MT)
Table 31. North America Somatostatin Analogs Sales Market Share by Country (2015-2020)
Table 32. North America Somatostatin Analogs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Somatostatin Analogs Revenue Market Share by Country (2015-2020)
Table 34. North America Somatostatin Analogs Sales by Type (2015-2020) (K MT)
Table 35. North America Somatostatin Analogs Sales Market Share by Type (2015-2020)
Table 36. North America Somatostatin Analogs Sales by Application (2015-2020) (K MT)
Table 37. North America Somatostatin Analogs Sales Market Share by Application (2015-2020)
Table 38. Europe Somatostatin Analogs Sales by Country (2015-2020) (K MT)
Table 39. Europe Somatostatin Analogs Sales Market Share by Country (2015-2020)
Table 40. Europe Somatostatin Analogs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Somatostatin Analogs Revenue Market Share by Country (2015-2020)
Table 42. Europe Somatostatin Analogs Sales by Type (2015-2020) (K MT)
Table 43. Europe Somatostatin Analogs Sales Market Share by Type (2015-2020)
Table 44. Europe Somatostatin Analogs Sales by Application (2015-2020) (K MT)
Table 45. Europe Somatostatin Analogs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Somatostatin Analogs Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Somatostatin Analogs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Somatostatin Analogs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Somatostatin Analogs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Somatostatin Analogs Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Somatostatin Analogs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Somatostatin Analogs Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Somatostatin Analogs Sales Market Share by Application (2015-2020)
Table 54. Latin America Somatostatin Analogs Sales by Country (2015-2020) (K MT)
Table 55. Latin America Somatostatin Analogs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Somatostatin Analogs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Somatostatin Analogs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Somatostatin Analogs Sales by Type (2015-2020) (K MT)
Table 59. Latin America Somatostatin Analogs Sales Market Share by Type (2015-2020)
Table 60. Latin America Somatostatin Analogs Sales by Application (2015-2020) (K MT)
Table 61. Latin America Somatostatin Analogs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Somatostatin Analogs Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Somatostatin Analogs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Somatostatin Analogs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Somatostatin Analogs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Somatostatin Analogs Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Somatostatin Analogs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Somatostatin Analogs Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Somatostatin Analogs Sales Market Share by Application (2015-2020)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Major Businesses
Table 72. Novartis Somatostatin Analogs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Novartis Product
Table 74. Novartis Recent Development
Table 75. Peptron Corporation Information
Table 76. Peptron Description and Major Businesses
Table 77. Peptron Somatostatin Analogs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Peptron Product
Table 79. Peptron Recent Development
Table 80. Chiasma Corporation Information
Table 81. Chiasma Description and Major Businesses
Table 82. Chiasma Somatostatin Analogs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Chiasma Product
Table 84. Chiasma Recent Development
Table 85. Ipsen Biopharmaceutical Corporation Information
Table 86. Ipsen Biopharmaceutical Description and Major Businesses
Table 87. Ipsen Biopharmaceutical Somatostatin Analogs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Ipsen Biopharmaceutical Product
Table 89. Ipsen Biopharmaceutical Recent Development
Table 90. Global Somatostatin Analogs Sales Forecast by Regions (2021-2026) (K MT)
Table 91. Global Somatostatin Analogs Sales Market Share Forecast by Regions (2021-2026)
Table 92. Global Somatostatin Analogs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 93. Global Somatostatin Analogs Revenue Market Share Forecast by Regions (2021-2026)
Table 94. North America: Somatostatin Analogs Sales Forecast by Country (2021-2026) (K MT)
Table 95. North America: Somatostatin Analogs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 96. Europe: Somatostatin Analogs Sales Forecast by Country (2021-2026) (K MT)
Table 97. Europe: Somatostatin Analogs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Asia Pacific: Somatostatin Analogs Sales Forecast by Region (2021-2026) (K MT)
Table 99. Asia Pacific: Somatostatin Analogs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 100. Latin America: Somatostatin Analogs Sales Forecast by Country (2021-2026) (K MT)
Table 101. Latin America: Somatostatin Analogs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Middle East and Africa: Somatostatin Analogs Sales Forecast by Country (2021-2026) (K MT)
Table 103. Middle East and Africa: Somatostatin Analogs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 105. Key Challenges
Table 106. Market Risks
Table 107. Main Points Interviewed from Key Somatostatin Analogs Players
Table 108. Somatostatin Analogs Customers List
Table 109. Somatostatin Analogs Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Somatostatin Analogs Product Picture
Figure 2. Global Somatostatin Analogs Sales Market Share by Type in 2020 & 2026
Figure 3. Octreotide Product Picture
Figure 4. Lanreotide Product Picture
Figure 5. Pasireotide Product Picture
Figure 6. Global Somatostatin Analogs Sales Market Share by Application in 2020 & 2026
Figure 7. Acromegaly
Figure 8. Carcinoid Syndrome
Figure 9. Neuroendocrine Tumor
Figure 10. Cushing Syndrome
Figure 11. Others
Figure 12. Somatostatin Analogs Report Years Considered
Figure 13. Global Somatostatin Analogs Market Size 2015-2026 (US$ Million)
Figure 14. Global Somatostatin Analogs Sales 2015-2026 (K MT)
Figure 15. Global Somatostatin Analogs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Somatostatin Analogs Sales Market Share by Region (2015-2020)
Figure 17. Global Somatostatin Analogs Sales Market Share by Region in 2019
Figure 18. Global Somatostatin Analogs Revenue Market Share by Region (2015-2020)
Figure 19. Global Somatostatin Analogs Revenue Market Share by Region in 2019
Figure 20. Global Somatostatin Analogs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Somatostatin Analogs Revenue in 2019
Figure 22. Somatostatin Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Somatostatin Analogs Sales Market Share by Type (2015-2020)
Figure 24. Global Somatostatin Analogs Sales Market Share by Type in 2019
Figure 25. Global Somatostatin Analogs Revenue Market Share by Type (2015-2020)
Figure 26. Global Somatostatin Analogs Revenue Market Share by Type in 2019
Figure 27. Global Somatostatin Analogs Market Share by Price Range (2015-2020)
Figure 28. Global Somatostatin Analogs Sales Market Share by Application (2015-2020)
Figure 29. Global Somatostatin Analogs Sales Market Share by Application in 2019
Figure 30. Global Somatostatin Analogs Revenue Market Share by Application (2015-2020)
Figure 31. Global Somatostatin Analogs Revenue Market Share by Application in 2019
Figure 32. North America Somatostatin Analogs Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Somatostatin Analogs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Somatostatin Analogs Sales Market Share by Country in 2019
Figure 35. North America Somatostatin Analogs Revenue Market Share by Country in 2019
Figure 36. U.S. Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Somatostatin Analogs Market Share by Type in 2019
Figure 41. North America Somatostatin Analogs Market Share by Application in 2019
Figure 42. Europe Somatostatin Analogs Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Somatostatin Analogs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Somatostatin Analogs Sales Market Share by Country in 2019
Figure 45. Europe Somatostatin Analogs Revenue Market Share by Country in 2019
Figure 46. Germany Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Somatostatin Analogs Market Share by Type in 2019
Figure 57. Europe Somatostatin Analogs Market Share by Application in 2019
Figure 58. Asia Pacific Somatostatin Analogs Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Somatostatin Analogs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Somatostatin Analogs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Somatostatin Analogs Revenue Market Share by Region in 2019
Figure 62. China Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Somatostatin Analogs Market Share by Type in 2019
Figure 85. Asia Pacific Somatostatin Analogs Market Share by Application in 2019
Figure 86. Latin America Somatostatin Analogs Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Somatostatin Analogs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Somatostatin Analogs Sales Market Share by Country in 2019
Figure 89. Latin America Somatostatin Analogs Revenue Market Share by Country in 2019
Figure 90. Mexico Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Somatostatin Analogs Market Share by Type in 2019
Figure 97. Latin America Somatostatin Analogs Market Share by Application in 2019
Figure 98. Middle East and Africa Somatostatin Analogs Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Somatostatin Analogs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Somatostatin Analogs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Somatostatin Analogs Revenue Market Share by Country in 2019
Figure 102. Turkey Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Somatostatin Analogs Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Somatostatin Analogs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Somatostatin Analogs Market Share by Type in 2019
Figure 109. Middle East and Africa Somatostatin Analogs Market Share by Application in 2019
Figure 110. North America Somatostatin Analogs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Somatostatin Analogs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Somatostatin Analogs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Somatostatin Analogs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Somatostatin Analogs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Somatostatin Analogs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Somatostatin Analogs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Somatostatin Analogs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Somatostatin Analogs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Somatostatin Analogs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
クッシング症候群・先端巨大症治療の世界市場（～2026年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. Acromegaly …- ソマトスタチン受容体4型の世界市場（～2026年） Market Analysis and Insights: Global Somatostatin Receptor Type 4 Market The global Somatostatin Receptor Type 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Somatostatin Receptor Type 4 Scope and Market Size Somato…
- ソマトスタチン受容体2型の世界市場（～2026年） Market Analysis and Insights: Global Somatostatin Receptor Type 2 Market The global Somatostatin Receptor Type 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Somatostatin Receptor Type 2 Scope and Market Size Somato…
- クッシング症候群治療の世界市場（～2026年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. In terms of…
- カルチノイド症候群下痢治療の世界市場（～2026年） Carcinoid syndrome is a group of symptoms that can occur in patients suffering from carcinoid tumors which also called as metastatic neuroendocrine tumors. Carcinoid tumors are rare and these are slow growing tumors. Most of the tumors occur in gastrointestinal tract. According to FDA, carcinoid syn…